Top Markets
Coin of the day
Elicio Therapeutics, Inc. Elicio Therapeutics, Inc.

Elicio Therapeutics, Inc.

ELTX
株式のランク #24646
Elicio Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to... Elicio Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to creating a diverse array of innovative immunotherapies for the treatment of various cancers and other diseases. The company's primary experimental drug, ELI-002, is an AMP therapeutic vaccine specifically formulated to target KRAS-driven cancers. Its development portfolio also encompasses ELI-004, an AMP-modified CpG adjuvant that forms part of ELI-002; ELI-007, a lymph node-targeted AMP-peptide vaccine addressing mutant BRAF-driven cancers; and ELI-008, a multivalent lymph node-targeted AMP-peptide vaccine for cancers expressing mutant TP53. Furthermore, Elicio is advancing ELI-005, a vaccine candidate for preventing COVID-19, and ELI-011 for hematological malignancies. Another program, ELI-012, is an mKRAS TCR T cell AMP-lifier designed for combined use with mKRAS-targeted TCR T cell therapy against mKRAS-driven cancers. The company's operations are headquartered in Boston, Massachusetts.
株価
$3.05
時価総額
$58.15M
変化(1日)
-0.81%
変化(1年)
-73.32%
US
取引 Elicio Therapeutics, Inc. (ELTX)

カテゴリー

Elicio Therapeutics, Inc.(ELTX)の株価履歴
終値の最高値: $3.10 (2026-08-01)

終値の最安値: $5.88 (2023-11-01)
Elicio Therapeutics, Inc. の株価履歴(2023 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) 9.17%
2025 59.27%
2024 -21.55%
2023 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$547.38 37.72%
US
$1.05K 58.85%
NL
$118.70 -18.24%
AU
$140.47 435.74%
US
$770.19 9.84%
CH